Shionogi & Co., Ltd. (OTCMKTS:SGIOY) Sees Large Decrease in Short Interest

Shionogi & Co., Ltd. (OTCMKTS:SGIOY) saw a significant decrease in short interest during the month of December. As of December 31st, there was short interest totalling 139,000 shares, a decrease of 27.8% from the December 15th total of 192,400 shares. Based on an average daily volume of 586,000 shares, the short-interest ratio is currently 0.2 days.

Shionogi & Co., Ltd. Price Performance

Shares of SGIOY stock traded up $0.10 on Friday, hitting $7.12. The stock had a trading volume of 194,338 shares, compared to its average volume of 261,931. The business has a 50 day moving average of $6.97 and a 200 day moving average of $8.77. The stock has a market cap of $12.11 billion, a price-to-earnings ratio of 12.14, a price-to-earnings-growth ratio of 4.78 and a beta of 0.21. Shionogi & Co., Ltd. has a 12-month low of $6.22 and a 12-month high of $9.11.

About Shionogi & Co., Ltd.

Shionogi & Co, Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-HIV and HIV prophylactic drug; Xocova an oral COVID-19 treatment drug; Finibax a carbapenem antibiotic; Xofluza, an influenza antiviral drug; and Tivicay, an anti-HIV drug.